Emerald Health Sciences Inc.

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Vancouver, British Columbia, Canada
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Stephen Hall, CFO of Emerald Health Sciences Inc.
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Emerald Health Sciences Inc.

Form 4 holding 10%+ Owner

Skye Bioscience, Inc.

Security class
Common Stock
Shares / value
169,407,901
Estimated value
$3,167,928
Report date
22 Feb 2023
Price
$0.0187
Ownership
Direct
Form 4 holding 10%+ Owner

Skye Bioscience, Inc.

Security class
Warrants
Shares / value
0
Estimated value
Report date
22 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Skye Bioscience, Inc.

Security class
Warrants with Credit Facility of Oct 5, 2018
Shares / value
0
Estimated value
Report date
22 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Skye Bioscience, Inc.

Security class
Warrants with Credit Facility of Oct 5, 2018 - T2
Shares / value
0
Estimated value
Report date
22 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Skye Bioscience, Inc.

Security class
Warrants with Credit Facility of Oct 5, 2018 - T3
Shares / value
0
Estimated value
Report date
22 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Emerald Health Sciences Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .